Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.

Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD.

Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. Epub 2012 Apr 30. Erratum in: Int J Psychiatry Clin Pract. 2012 Sep;16(3):242. Int J Psychiatry Clin Pract. 2013 Feb;17(1):76.

PMID:
22540422
2.

The nature, assessment, and treatment of obsessive-compulsive disorder.

McGuire JF, Lewin AB, Horng B, Murphy TK, Storch EA.

Postgrad Med. 2012 Jan;124(1):152-65. doi: 10.3810/pgm.2012.01.2528. Review.

PMID:
22314125
3.

Obsessive compulsive disorder.

Soomro GM.

BMJ Clin Evid. 2012 Jan 18;2012. pii: 1004. Review.

4.

Inositol treatment of obsessive-compulsive disorder.

Fux M, Levine J, Aviv A, Belmaker RH.

Am J Psychiatry. 1996 Sep;153(9):1219-21.

PMID:
8780431
5.

A review of obsessive-compulsive disorder in children and adolescents.

Boileau B.

Dialogues Clin Neurosci. 2011;13(4):401-11. Review.

6.

Role of serotonin in obsessive-compulsive disorder.

Baumgarten HG, Grozdanovic Z.

Br J Psychiatry Suppl. 1998;(35):13-20. Review.

PMID:
9829022
7.

Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.

Marazziti D, Carlini M, Dell'Osso L.

Curr Top Med Chem. 2012;12(4):238-53. Review.

PMID:
22204483
8.

Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.

Fontenelle LF, Oostermeijer S, Harrison BJ, Pantelis C, Yücel M.

Drugs. 2011 May 7;71(7):827-40. doi: 10.2165/11591790-000000000-00000. Review.

PMID:
21568361
10.

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

Askari N, Moin M, Sanati M, Tajdini M, Hosseini SM, Modabbernia A, Najand B, Salimi S, Tabrizi M, Ashrafi M, Hajiaghaee R, Akhondzadeh S.

CNS Drugs. 2012 Oct 1;26(10):883-92. doi: 10.2165/11635850-000000000-00000.

PMID:
22873680
11.

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence.

Camfield DA, Sarris J, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):887-95. doi: 10.1016/j.pnpbp.2011.02.011. Epub 2011 Feb 23. Review.

PMID:
21352883
12.

Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review.

Sarris J, Camfield D, Berk M.

J Affect Disord. 2012 May;138(3):213-21. doi: 10.1016/j.jad.2011.04.051. Epub 2011 May 26. Review.

PMID:
21620478
13.

Obsessive compulsive disorder with psychotic features.

Eisen JL, Rasmussen SA.

J Clin Psychiatry. 1993 Oct;54(10):373-9.

PMID:
8262879
14.

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.

Wu K, Hanna GL, Rosenberg DR, Arnold PD.

Pharmacol Biochem Behav. 2012 Feb;100(4):726-35. doi: 10.1016/j.pbb.2011.10.007. Epub 2011 Oct 15. Review.

15.

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, Sanacora G, Krystal JH, Coric V.

Psychopharmacology (Berl). 2006 Jan;184(2):254-6. Epub 2005 Dec 22.

PMID:
16374600
16.

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Bruno A, Micò U, Pandolfo G, Mallamace D, Abenavoli E, Di Nardo F, D'Arrigo C, Spina E, Zoccali RA, Muscatello MR.

J Psychopharmacol. 2012 Nov;26(11):1456-62. doi: 10.1177/0269881111431751. Epub 2012 Feb 20.

PMID:
22351381
17.

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

Moreno FA, Wiegand CB, Taitano EK, Delgado PL.

J Clin Psychiatry. 2006 Nov;67(11):1735-40.

PMID:
17196053
18.

Genome-wide association study of obsessive-compulsive disorder.

Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Davis LK, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Edlund CK, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MA, Cook EH Jr, Kennedy JL, Rosenberg D, Stein DJ, Hemmings SM, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra-VanderWeele J, Denys D, Blom R, Deforce D, Van Nieuwerburgh F, Westenberg HG, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do Rosário M, Sampaio AS, Vallada H, Nicolini H, Lanzagorta N, Camarena B, Delorme R, Leboyer M, Pato CN, Pato MT, Voyiaziakis E, Heutink P, Cath DC, Posthuma D, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Coric V, Leckman JF, Bloch M, Pittenger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Cookson MR, Singleton A; North American Brain Expression Consortium, Hardy J; UK Brain Expression Database, Crenshaw AT, Parkin MA, Mirel DB, Conti DV, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL.

Mol Psychiatry. 2013 Jul;18(7):788-98. doi: 10.1038/mp.2012.85. Epub 2012 Aug 14. Erratum in: Mol Psychiatry. 2013 Jul;18(7):843. Davis, L K [added].

19.

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Dold M, Aigner M, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Review.

PMID:
22932229
20.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942

Supplemental Content

Support Center